Correlation Between Diffusion Pharmaceuticals and Actinium Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Actinium Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Actinium Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Actinium Pharmaceuticals, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Actinium Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Actinium Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Actinium Pharmaceuticals.
Diversification Opportunities for Diffusion Pharmaceuticals and Actinium Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Diffusion and Actinium is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Actinium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinium Pharmaceuticals and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Actinium Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinium Pharmaceuticals has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Actinium Pharmaceuticals go up and down completely randomly.
Pair Corralation between Diffusion Pharmaceuticals and Actinium Pharmaceuticals
Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to generate 0.5 times more return on investment than Actinium Pharmaceuticals. However, Diffusion Pharmaceuticals is 2.0 times less risky than Actinium Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Actinium Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 381.00 in Diffusion Pharmaceuticals on August 30, 2024 and sell it today you would lose (54.00) from holding Diffusion Pharmaceuticals or give up 14.17% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 13.71% |
Values | Daily Returns |
Diffusion Pharmaceuticals vs. Actinium Pharmaceuticals
Performance |
Timeline |
Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Actinium Pharmaceuticals |
Diffusion Pharmaceuticals and Actinium Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Diffusion Pharmaceuticals and Actinium Pharmaceuticals
The main advantage of trading using opposite Diffusion Pharmaceuticals and Actinium Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Actinium Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinium Pharmaceuticals will offset losses from the drop in Actinium Pharmaceuticals' long position.Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
Actinium Pharmaceuticals vs. Mink Therapeutics | Actinium Pharmaceuticals vs. Affimed NV | Actinium Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Actinium Pharmaceuticals vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Transaction History View history of all your transactions and understand their impact on performance |